Rate My Professor Rosemary Hall

Associate Professor Rosemary Hall, MBChB, FRACP, PhD, is an endocrinologist and academic in the Department of Medicine at the University of Otago, Wellington, part of the Faculty of Medicine within the Health Sciences Division. She completed her PhD at the University of Cambridge, UK, investigating the association between dietary protein intake, energy regulation, and metabolic disease. Her doctoral research employed advanced methodologies, including whole body calorimetry, to assess energy intake and expenditure, body composition, and metabolic parameters in controlled physiological studies. Professionally, she practices as an endocrinologist specializing in general endocrinology and diabetes at Capital and Coast District Health Board, where she leads the regional diabetes in pregnancy clinical service for the Wellington area. This role underscores her clinical expertise in managing diabetes during pregnancy and related complications.

Hall's research interests center on the links between diabetes in pregnancy and subsequent diabetes development in later life, as well as the relationships among obesity, energy regulation, and diabetes. She secured a Health Research Council feasibility grant (HRC15/513) to examine long-term outcomes for women attending the diabetes in pregnancy clinic. Her scholarly contributions include over 40 publications, amassing more than 800 citations. Notable works feature the Australasian Diabetes in Pregnancy Society 2025 consensus recommendations for gestational diabetes screening, diagnosis, and classification (Sweeting et al., Medical Journal of Australia, 2025); a scoping review on enablers and barriers to dietary change for Māori with nutrition-related conditions (McKerchar et al., 2024); enablers and challenges of dietary interventions for Pacific peoples (Amataiti et al., Nutrition Reviews, 2025); and the ACCESS-AID study protocol for automated insulin delivery in type 1 diabetes (Gale et al., Journal of Diabetes & Metabolic Disorders, 2026). Additional key papers address interpregnancy weight change, potential interactions between metformin and dietary fiber in type 2 diabetes, and Polynesian-specific genetic variants in lipoprotein(a). Her expertise extends to diabetes technologies, type 1 and type 2 diabetes, human nutrition, and obesity, influencing clinical guidelines and interventions tailored to New Zealand's diverse populations, including Māori and Pacific communities.